Penumbra has announced the launch of its new mechanical thrombectomy system, known as Lightning Flash, which helps remove large blood clots in the body, including venous thrombus and pulmonary emboli (PE).

The thrombectomy system has received approval from the US Food and Drug Administration (FDA).

Powered by the Penumbra ENGINE, Lightning Flash combines the company’s new Lightning Intelligent Aspiration technology and dual clot detection algorithms.

Along with advanced catheter engineering, it can remove blood clots in the body quickly while reducing potential blood loss.

Penumbra chief medical officer James Benenati said: “Penumbra’s Lightning Flash gives physicians a highly torqueable, larger catheter that is designed to remove a large clot burden in the pulmonary arteries or deep venous system more efficiently while maintaining an excellent safety profile because of Lightning’s computer-aided algorithms.

“We believe that patients can have improved outcomes with this new technology because of the exceptional trackability and unique ability to distinguish flowing blood from clot.”

Lightning Flash is part of the Penumbra Indigo System with Lightning portfolio and can detect blood clots and flow using a combination of pressure and flow-based algorithms.

Its catheter is made using MaxID hypotube technology, which allows an inner diameter that is similar to large-bore catheters while maintaining a soft, atraumatic tip that helps navigate the body’s complex and delicate anatomy.

Penumbra president and CEO Adam Elsesser said: “With this latest advancement, physicians are more likely to adopt mechanical thrombectomy because a broad spectrum of blood clots can be removed much quicker and less invasively than current interventional or surgical methods.”